Role of Cyclin D1b in Inducing Macrophages Toward a Tumor-associated Macrophage-like Phenotype in Murine Breast Cancer

Abstract

Objective

Tumor-associated macrophages (TAMs) of the M2 phenotype are frequently associated with cancer progression. Invasive cancer cells undergoing epithelial-mesenchymal transition (EMT) have a selective advantage as TAM activators. Cyclin D1b is a highly oncogenic splice variant of cyclin D1. We previously reported that cyclin D1b enhances the invasiveness of breast cancer cells by inducing EMT. However, the role of cyclin D1b in inducing macrophage differentiation toward tumor-associated macrophage-like cells remains unknown. This study aimed to explore the relationship between breast cancer cells overexpressing cyclin D1b and TAMs.

Methods

Mouse breast cancer 4T1 cells were transfected with cyclin D1b variant and co-cultured with macrophage cells in a Transwell coculture system. The expression of characteristic cytokines in differentiated macrophages was detected using qRT-PCR, ELISA and zymography assay. Tumor-associated macrophage distribution in a transplanted tumor was detected by immunofluorescence staining. The proliferation and migration ability of breast cancer cells was detected using the cell counting kit-8 (CCK-8) assay, wound healing assay, Transwell invasion assay, and lung metastasis assay. Expression levels of mRNAs were detected by qRT-PCR. Protein expression levels were detected by Western blotting. The integrated analyses of The Cancer Genome Atlas (TCGA) datasets and bioinformatics methods were adopted to discover gene expression, gene coexpression, and overall survival in patients with breast cancer.

Results

After co-culture with breast cancer cells overexpressing cyclin D1b, RAW264.7 macrophages were differentiated into an M2 phenotype. Moreover, differentiated M2-like macrophages promoted the proliferation and migration of breast cancer cells in turn. Notably, these macrophages facilitated the migration of breast cancer cells in vivo. Further investigations indicated that differentiated M2-like macrophages induced EMT of breast cancer cells accompanied with upregulation of TGF-β1 and integrin β3 expression.

Conclusion

Breast cancer cells transfected with cyclin D1b can induce the differentiation of macrophages into a tumor-associated macrophage-like phenotype, which promotes tumor metastasis in vitro and in vivo.

Keywords

cyclin D1b / tumor-associated macrophages / breast cancer / transforming growth factor-β1 / integrin β3 / epithelial-to-mesenchymal transition

References

[1] KnudsenKE, DiehlJA, HaimanCA, et al.. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene, 2006, 25(11): 1620-1628

[2] WangY, DeanJL, MillarEKA, et al.. Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists. Cancer Res, 2008, 68(14): 5628-5638

[3] AugelloMA, Berman-BootyLD, CarrR3rd, et al.. Consequence of the tumor-associated conversion to cyclin D1b. EMBO Mol Med, 2015, 7(5): 628-647

[4] LuF, GladdenAB, DiehlJA. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res, 2003, 63(21): 7056-7061

[5] KimCJ, TambeY, MukaishoK, et al.. Female-specific rectal carcinogenesis in cyclin D1b transgenic mice. Carcinogenesis, 2014, 35(1): 227-236

[6] WuFH, LuoLQ, LiuY, et al.. Cyclin D1b splice variant promotes αvβ3-mediated adhesion and invasive migration of breast cancer cells. Cancer Lett, 2014, 355(1): 159-167

[7] LuoBP, LuoJ, HuYB, et al.. Cyclin D1b splice variant promotes αvβ3-mediated EMT induced by LPS in breast cancer cells. Curr Med Sci, 2018, 38(3): 467-472

[8] SolinasG, GermanoG, MantovaniA, et al.. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukocyte Biol, 2009, 86(5): 1065-1073

[9] MantovaniA, SozzaniS, LocatiM, et al.. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol, 2002, 23(11): 549-555

[10] TangX. Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. Cancer Lett, 2013, 332(1): 3-10

[11] MaR, JiT, ChenD, et al.. Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progression. Oncoimmunology, 2016, 5(4): e1118599

[12] WyckoffJ, WangW, LinEY, et al.. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res, 2004, 64(19): 7022-7029

[13] RolliM, FransveaE, PilchJ, et al.. Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci USA, 2003, 100(16): 9482-9487

[14] HoefelD, GroobyWL, MonisPT, et al.. A comparative study of carboxyfluorescein diacetate and carboxyfluorescein diacetate succinimidyl ester as indicators of bacterial activity. J Microbiol Methods, 2003, 52(3): 379-388

[15] NoëlW, RaesG, GhassabehGH, et al.. Alternatively activated macrophages during parasite infections. Trends Parasitol, 2004, 20(3): 126-133

[16] PengJ, TsangJYS, LiD, et al.. Inhibition of TGF-β signaling in combination with TLR7 ligation reprograms a tumoricidal phenotype in tumor-associated macrophages. Cancer Lett, 2013, 331(2): 239-249

[17] GuiducciC, VicariAP, SangalettiS, et al.. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res, 2005, 65(8): 3437-3446

[18] JouanguyE, DöffingerR, DupuisS, et al.. IL-12 and IFN-γ in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol, 1999, 11(3): 346-351

[19] SicaA, MantovaniA. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest, 2012, 122(3): 787-795

[20] KataraGK, KulshresthaA, JaiswalMK, et al.. Inhibition of vacuolar ATPase subunit in tumor cells delays tumor growth by decreasing the essential macrophage population in the tumor microenvironment. Oncogene, 2016, 35(8): 1058-1065

[21] YeXZ, XuSL, XinYH, et al.. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway. J Immunol, 2012, 189(1): 444-453

[22] BlumA, WangP, ZenklusenJC. SnapShot: TCGA-analyzed tumors. Cell, 2018, 173(2): 530

[23] SousaS, BrionR, LintunenM, et al.. Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Res, 2015, 17(1): 101

[24] KimCJ, TambeY, MukaishoKI, et al.. Akt-dependent activation of Erk by cyclin D1b contributes to cell invasiveness and tumorigenicity. Oncol Lett, 2016, 12(6): 4850-4856

[25] GaldieroMR, BonavitaE, BarajonI, et al.. Tumor associated macrophages and neutrophils in cancer. Immunobiology, 2013, 218(11): 1402-1410

[26] LorgerM, Felding-HabermannB. Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. Am J Pathol, 2010, 176(6): 2958-2971

[27] ChoiJ, GyamfiJ, JangH, et al.. The role of tumor-associated macrophage in breast cancer biology. Histol Histopathol, 2018, 33(2): 133-145

[28] SuS, LiuQ, ChenJ, et al.. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell, 2014, 25(5): 605-620

[29] LiuF, QiuH, XueM, et al.. MSC-secreted TGF-β regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the Akt/FoxO1 pathway. Stem Cell Res Ther, 2019, 10(1): 345

[30] ZhangF, WangH, WangX, et al.. TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype. Oncotarget, 2016, 7(32): 52294-52306

[31] DesgrosellierJS, ChereshDA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer, 2010, 10(1): 9-22